The Krill Ageing Muscle Mechanisms (KAMM) Study - Trial NCT06296875
Access comprehensive clinical trial information for NCT06296875 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Glasgow and is currently Not yet recruiting. The study focuses on Sarcopenia. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Glasgow
Timeline & Enrollment
N/A
Mar 01, 2024
Mar 01, 2026
Primary Outcome
Grip strength,Neuromuscular junction transmission instability,Gait speed
Summary
This study aims to determine the mechanisms via which krill oil supplementation increases
 muscle strength and whether this translates to improvements in gait and functional
 characteristics in older adults. The studies we will carry out will establish, in healthy
 older adults, the effects of 6 months of supplementation with krill oil
 
 Objective 1) Muscle structure and function Hypothesis: Krill oil supplementation will
 increase muscle size and strength alongside positive changes in muscle architecture
 (pennation angle and fascicle length).
 
 Objective 2) Neuromuscular control and central nervous system (CNS) function Hypothesis:
 Krill oil supplementation will improve Neuromuscular Junction (NMJ) transmission stability
 and increase central drive and intramuscular coherence, as a measure of muscle synergy.
 
 Objective 3) Gait and functional characteristics Hypothesis: Krill oil supplementation will
 improve gait and functional characteristics.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06296875
Non-Device Trial